To Evaluate the Performance of HepaSphere Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy on Unresectable Colorectal Liver Metastases
Clinical trial NCT05889325 · UNKNOWN
Trial details
- NCT number
- NCT05889325
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-07-01
- Primary completion
- 2023-09-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.